Squarepoint Ops LLC Trevena Inc Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $26,259 - $40,468	-17,986 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.77 - $2.93 $371,491 - $614,954	-209,882 Reduced 92.11%	17,986 $32,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $485,358 - $742,849	227,868 New	227,868 $488,000
Q2 2020 Aug 14, 2020	SELL	$0.48 - $1.75 $6,075 - $22,149	-12,657 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.56 - $0.97 $7,087 - $12,277	12,657 New	12,657 $7,000
Q3 2019 Nov 14, 2019	SELL	$0.81 - $1.06 $11,322 - $14,816	-13,978 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $24,950 - $42,468	-26,543 Reduced 65.5%	13,978 $14,000
Q1 2019 May 15, 2019	SELL	$0.51 - $1.88 $4,849 - $17,876	-9,509 Reduced 19.01%	40,521 $63,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $3.47 $2,204 - $19,615	-5,653 Reduced 10.15%	50,030 $22,000
Q3 2018 Nov 14, 2018	BUY	$1.39 - $2.25 $36,202 - $58,601	26,045 Added 87.88%	55,683 $118,000
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $42,678 - $66,389	29,638 New	29,638 $43,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $650M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.